Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 616.40
+1.35 (0.22%)
Mar 6, 2026, 3:27 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 7.18 billion as of March 6, 2026. Its market cap has decreased by -40.90% in one year.
Market Cap
7.18B
Enterprise Value
7.44B
Revenue
7.48B
Ranking
n/a
PE Ratio
22.50
Stock Price
616.40
Market Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 7.18B, an increase of 171.24%. That is a compound annual growth rate of 43.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 7.17B | -12.41% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 7.27B |
| Infinium Pharmachem | 3.26B |
| Quest Laboratories | 1.88B |
| Sotac Pharmaceuticals | 1.23B |
| Zenith Drugs | 840.29M |
| Vilin Bio Med | 471.51M |
| Medicamen Organics | 266.76M |
| Sunrest Lifescience | 188.81M |